Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.

The ADAPT trial involves 70 refractory glaucoma patients, focusing on a 12-month primary effectiveness endpoint to evaluate the Calibreye TGT Surgical System. The Calibreye system is the first ...

As part of its ongoing product development, ROHM also confirmed it is working on a higher-power, 3216-size sintered metal ...

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

Myra Vision, a Shifamed portfolio company, today announced the first patient enrolled in its ADAPT clinical study evaluating ...

ROHM has developed the UCR10C Series, delivering the industry's highest rated power for 2012-size shunt resistors (10mΩ to 100mΩ).

ROHM has developed the “UCR10C Series” which claims to deliver the industry’s highest rated power for 2012-size shunt ...

Santa Clara, CA and Kyoto, Japan, Jan. 22, 2026 (GLOBE NEWSWIRE) -- ROHM today announced it has developed the “ UCR10C Series ”, which has the industry's highest rated power for 2012-size shunt ...

Using information in medical records for more than 1,100 emergency room visits, researchers at Johns Hopkins Children's ...

Bear, the one-year-old cat whose dramatic rescue from a 50-foot tree near McQueen High School after a lightning and ...

President Donald Trump has taken a bold step in his campaign to yank Venezuela back from the brink and to keep China out of the Western Hemisphere. Operation Absolute Resolve was a stunning tactical ...